...
首页> 外文期刊>European journal of dermatology: EJD >Fascin, cortactin and survivin expression of melanocytic neoplasms and association with clinicopathological parameters and anatomic locations in Chinese people.
【24h】

Fascin, cortactin and survivin expression of melanocytic neoplasms and association with clinicopathological parameters and anatomic locations in Chinese people.

机译:中国人黑素细胞瘤的fascin,cortactin和survivin表达及其与临床病理参数和解剖位置的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

Distinct genetic aberrations between melanomas in different anatomical locations have been confirmed in recent years. However, the associations between immunohistochemical expression, tumor sites, and clinical parameters are not clear. We examined the correlation of protein expression of fascin, cortactin and survivin with clinicopathological parameters and lesion locations in patients with cutaneous melanoma. We collected 170 melanocytic lesions, including 106 cutaneous malignant melanoma (MM) from acral (AM) and non-acral (NAM) sites, 24 dysplastic nevi (DN), and 40 common melanocytic nevi (CMN). Tissue micro arrays were constructed and immunohistochemical expression for cortactin, fascin, and survivin was assessed with correlation with clinical parameters. Cytoplasmic immunostaining for fascin was found to be significantly higher in CMN than DN, and survivin staining was significantly higher in DN than MM. Positive nuclear immunoreactivity for survivin was seen in a large subset of melanomas but much less frequently in CMN and DN. In addition, nuclear survivin immunoreactivity was significantly more common in NAM than in AM. Nuclear survivin staining in patients with NAM was significantly correlated with poor survival. The significantly different expression of immunoreactivities (nuclear survivin) between AM and NAM and the different mortality risks of melanomas on acral versus non-acral sites might change site-specific therapeutic concepts in melanoma.
机译:近年来,在不同解剖位置的黑色素瘤之间存在明显的遗传异常。但是,免疫组织化学表达,肿瘤部位和临床参数之间的关联尚不清楚。我们检查了皮肤黑素瘤患者中fascin,cortactin和survivin的蛋白表达与临床病理参数和病变部位的相关性。我们收集了170个黑素细胞病灶,包括106个皮肤性恶性黑色素瘤(MM),分别来自末端(AM)和非末端(NAM),24个增生性痣(DN)和40个常见的黑色素性痣(CMN)。构建组织微阵列,并评估cortactin,fascin和survivin的免疫组织化学表达,并将其与临床参数相关联。发现肌成束蛋白的细胞质免疫染色在CMN中显着高于DN,而在DN中survivin染色显着高于MM。 Survivin的阳性核免疫反应性在黑色素瘤的很大一部分中被发现,而在CMN和DN中则很少见。此外,NAM中核存活蛋白的免疫反应性显着高于AM。 NAM患者的核survivin染色与不良生存率显着相关。 AM和NAM之间的免疫反应性(核存活蛋白)表达明显不同,并且黑头瘤在端头和非头端的死亡风险不同,这可能会改变黑素瘤中针对位点的治疗概念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号